Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.

NCT01295021 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01295021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01295021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
February 29, 2012
Enrollment
1,514 (actual)
Sites
97

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension